Elacytarabine
Elacytarabine (CP 4055) is a lipid-conjugated derivative of the nucleoside analog cytarabine. Elacytarabine (CP 4055) is an antineoplastic agent with cytotoxicity in solid tumors.
Product Specifications
CAS Number
[188181-42-2]
Product Name Alternative
CP 4055
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CP_4055.html
Purity
98.0
Solubility
DMSO : 125 mg/mL (ultrasonic) |Ethanol : 4 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCC/C=C/CCCCCCCC(OC[C@H]([C@@H](O)[C@@H]1O)O[C@H]1N2C(N=C(N)C=C2)=O)=O
Molecular Formula
C27H45N3O6
Molecular Weight
507.66
Precautions
H302, H315, H319, H335
References & Citations
[1]DiNardo CD, et al. Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia. Future Oncol. 2013 Aug;9 (8) :1073-82.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CD226 (CD226 Antigen, Adhesion Glycoprotein, DNAX Accessory Molecule 1, DNAM1, DNAM-1, Platelet and T cell Activation Antigen 1, PTA1, TLiSA1) (PE)
Recombinant Escherichia coli O6:K15:H31 D-tagatose-1,6-bisphosphate aldolase subunit kbaZ (kbaZ)